Business & Industry
Sanofi and Snowflake Team Up to Deploy AI-Powered Field Agent Support Tool
Sanofi has partnered with cloud data platform company Snowflake to develop an artificial intelligence-driven tool designed to assist the pharmaceutical giant's field sales representatives in their day-to-day operations. The collaboration aims to give Sanofi's field agents faster, more efficient...
Business & Industry
Aragen Backs Renaissance Rare Disease Therapy Launch
Contract research, development, and manufacturing organization (CRDMO) Aragen has announced the successful production of the first commercial-scale GMP batches of Daretabart (hu1418K322A), the lead therapeutic candidate of UK-based Renaissance Pharma Limited. The milestone marks a key step forward in...
Business & Industry
Eli Lilly and Haisco Pharmaceutical Enter $3Billion+ Deal
Eli Lilly has entered into a multi-program collaboration with Beijing-based Haisco Pharmaceutical Group, committing an upfront payment of $87 million and exposing itself to up to $2.97 billion in potential milestone payments. The total value of the arrangement could...
Business & Industry
Lilly Signs $1.26bn Sonefpeglutide Licensing Deal with Hanmi
Eli Lilly and Company and Hanmi Pharm have officially finalized a comprehensive licensing agreement. Under the terms of the worldwide arrangement, Sonefpeglutide licensing is for global development, manufacturing, and commercialization, excluding the South Korean market. The financial framework includes...
News
Pharmacogenomics in 2026: From Research Concept to Clinical Workflow
Pharmacogenomics has moved well beyond the research phase. In 2026, healthcare systems are using genetic insights as part of routine prescribing decisions, especially in areas such as oncology, cardiology, psychiatry, and pain management. What once sat inside academic journals...
Business & Industry
Pfizer and Innovent Finalize $10.5 Billion Global Oncology Agreement
The Pfizer Innovent Cancer Deal has been finalized, establishing a global licensing and collaboration agreement valued at up to $10.5 billion. The transaction focuses on the research, development, and commercialization of 12 early-stage oncology programs. This arrangement combines the...
News
The Push for Greater Accuracy in Clinical Trials
Clinical trials are the foundation of modern medicine. Every treatment, therapy, and medical breakthrough relies on accurate research to ensure safety and effectiveness. However, maintaining accuracy across complex studies has always been a challenge. With large patient populations, multiple...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read